Practicing aggressive innovation.

Bringing high-value therapies to the patients who need them requires a keen eye for potential and a dedication to accelerating the development of late-stage assets. We have both.

We are always interested in collaborating with development, manufacturing, and commercialization partners to bring innovative products to patients living with rare diseases.

Keeping the flow going.

Alkindi^® Sprinkle

Status: Commercial Marketing Partner: Eton

Alaway^® Preservative Free

Status: Commercial Marketing Partner: Bausch Health

Biorphen^®

Status: Commercial Marketing Partner: Xellia Pharmaceuticals

Dehydrated Alcohol Injection

Status: Filed

Zonisamide Oral Suspension

Status: Filed Marketing Partner: Azurity Pharmaceuticals

Ephedrine Injection

Status: Filed Marketing Partner: Eton/TBD

EPRONTIA™ Oral Solution

Status: Approved Marketing Partner: Azurity Pharmaceuticals

Lamotrigine Oral Suspension

Status: Filed Marketing Partner: Azurity Pharmaceuticals

Cysteine Injection

Status: Filed Marketing Partner: Eton/TBD

Carglumic Acid Tablets

Status: Commercial

Interested in a partnership?

Let’s start the conversation.

Partner with us